Who
Kyri K. Van Hoose
SVP, CFO
Company insider
Files Form 4 as: SVP, CFO, Dermata Therapeutics.
In numbers
- Trades disclosed
- 20
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Sep 2021
- Last trade
- 16 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Aug 2026filed 18 Aug 2026 | DRMA Dermata TherapeuticsBiotechnology | SEC FORM 4 Code A | —102,040 | filing |
| 16 Aug 2026filed 18 Aug 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —102,040 | filing |
| 16 Aug 2026filed 18 Aug 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —102,040 | filing |
| 16 Aug 2026filed 18 Aug 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —102,040 | filing |
| 16 Aug 2026filed 18 Aug 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —102,040 | filing |
| 16 Aug 2026filed 18 Aug 2026 | DRMA Dermata TherapeuticsBiotechnology | SEC FORM 4 Code A | —102,040 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,000 at $0.00 | filing |
| 23 Dec 2025filed 29 Dec 2025 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —122,549 | filing |
| 23 Dec 2025filed 29 Dec 2025 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —122,549 | filing |
| 23 Dec 2025filed 29 Dec 2025 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —7,874 | filing |
| 23 Dec 2025filed 29 Dec 2025 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,874 | filing |
| 23 Dec 2025filed 29 Dec 2025 | DRMA Dermata TherapeuticsBiotechnology | SEC FORM 4 Code A | —122,549 | filing |
| 21 Jan 2025filed 23 Jan 2025 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —78,741 | filing |
| 21 Jan 2025filed 23 Jan 2025 | DRMA Dermata TherapeuticsBiotechnology | SEC FORM 4 Code A | —78,741 | filing |
| 13 Jan 2025filed 14 Jan 2025 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 4 Jan 2024filed 5 Jan 2024 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 3 Jan 2022filed 5 Jan 2022 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 1 Sep 2021filed 1 Sep 2021 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.